Skip to main content
. Author manuscript; available in PMC: 2011 Aug 9.
Published in final edited form as: Antivir Ther. 2011;16(5):667–675. doi: 10.3851/IMP1815

Figure 3. Predictors of development of clinical events in coinfected participants.

Figure 3

HA: hyaluronic acid, DC: drug conservation, VS: viral suppression

Predictors included in the models are treatment group, baseline HA categories, age gender, race, prior AIDS, baseline HIV-RNA, baseline CD4+, nadir CD4+, baseline ART status, history of alcohol abuse and HBV+ status.